56 related articles for article (PubMed ID: 18534705)
1. HPMA copolymer-doxorubicin-gadolinium conjugates: synthesis, characterization, and in vitro evaluation.
Zarabi B; Nan A; Zhuo J; Gullapalli R; Ghandehari H
Macromol Biosci; 2008 Aug; 8(8):741-8. PubMed ID: 18484565
[TBL] [Abstract][Full Text] [Related]
2. Treatment with HPMA copolymer-based doxorubicin conjugate containing human immunoglobulin induces long-lasting systemic anti-tumour immunity in mice.
Sirova M; Strohalm J; Subr V; Plocova D; Rossmann P; Mrkvan T; Ulbrich K; Rihova B
Cancer Immunol Immunother; 2007 Jan; 56(1):35-47. PubMed ID: 16636810
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin plus tumor necrosis factor alpha combination treatments in EL4-lymphoma-bearing C57BL/6 mice.
Ehrke MJ; Verstovsek S; Ujházy P; Meer JM; Eppolito C; Maccubbin DL; Mihich E
Cancer Immunol Immunother; 1998 Feb; 45(6):287-98. PubMed ID: 9490198
[TBL] [Abstract][Full Text] [Related]
4. The cytoplasmic escape and nuclear accumulation of endocytosed and microinjected HPMA copolymers and a basic kinetic study in Hep G2 cells.
Jensen KD; Kopecková P; Bridge JH; Kopecek J
AAPS PharmSci; 2001; 3(4):E32. PubMed ID: 12049495
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone nanomedicines with optimized drug release kinetics tailored for treatment of site-specific rheumatic musculoskeletal diseases.
Libánská A; Randárová E; Rubanová D; Skoroplyas S; Bryja J; Kubala L; Konefal R; Navrátilová A; Cerezo LA; Šenolt L; Etrych T
Int J Pharm; 2024 Apr; 654():123979. PubMed ID: 38458405
[TBL] [Abstract][Full Text] [Related]
6. Chemical modification of bradykinin-polymer conjugates for optimum delivery of nanomedicines to tumors.
Appiah E; Nakamura H; Assumang A; Etrych T; Haratake M
Nanomedicine; 2024 Apr; 57():102744. PubMed ID: 38460653
[TBL] [Abstract][Full Text] [Related]
7. Poly(
Alfurhood JA; Sun H; Kabb CP; Tucker BS; Matthews JH; Luesch H; Sumerlin BS
Polym Chem; 2017 Sep; 8(34):4983-4987. PubMed ID: 28959359
[TBL] [Abstract][Full Text] [Related]
8. Dendrimer: An update on recent developments and future opportunities for the brain tumors diagnosis and treatment.
Kaurav M; Ruhi S; Al-Goshae HA; Jeppu AK; Ramachandran D; Sahu RK; Sarkar AK; Khan J; Ashif Ikbal AM
Front Pharmacol; 2023; 14():1159131. PubMed ID: 37006997
[TBL] [Abstract][Full Text] [Related]
9. Tumor Stimulus-Responsive Biodegradable Diblock Copolymer Conjugates as Efficient Anti-Cancer Nanomedicines.
Šubr V; Pola R; Gao S; Islam R; Hirata T; Miyake D; Koshino K; Zhou JR; Yokomizo K; Fang J; Etrych T
J Pers Med; 2022 Apr; 12(5):. PubMed ID: 35629120
[TBL] [Abstract][Full Text] [Related]
10. Structurally nanoengineered antimicrobial peptide polymers: design, synthesis and biomedical applications.
Ramamurthy R; Mehta CH; Nayak UY
World J Microbiol Biotechnol; 2021 Jul; 37(8):139. PubMed ID: 34278535
[TBL] [Abstract][Full Text] [Related]
11. HPMA Copolymer-Based Nanomedicines in Controlled Drug Delivery.
Chytil P; Kostka L; Etrych T
J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33578756
[TBL] [Abstract][Full Text] [Related]
12. Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and Imaging.
Glasgow MD; Chougule MB
J Biomed Nanotechnol; 2015 Nov; 11(11):1859-98. PubMed ID: 26554150
[TBL] [Abstract][Full Text] [Related]
13. Preparation, drug release, and cell growth inhibition of a gelatin: doxorubicin conjugate.
Wu DC; Cammarata CR; Park HJ; Rhodes BT; Ofner CM
Pharm Res; 2013 Aug; 30(8):2087-96. PubMed ID: 23686374
[TBL] [Abstract][Full Text] [Related]
14. Biological rationale for the design of polymeric anti-cancer nanomedicines.
Zhou Y; Kopeček J
J Drug Target; 2013 Jan; 21(1):1-26. PubMed ID: 23009337
[TBL] [Abstract][Full Text] [Related]
15. Polymeric conjugates for drug delivery.
Larson N; Ghandehari H
Chem Mater; 2012 Mar; 24(5):840-853. PubMed ID: 22707853
[TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of linear HPMA-doxorubicin conjugates with pH-sensitive drug release: efficacy, safety, and immunomodulating activity in murine model.
Sirova M; Mrkvan T; Etrych T; Chytil P; Rossmann P; Ibrahimova M; Kovar L; Ulbrich K; Rihova B
Pharm Res; 2010 Jan; 27(1):200-8. PubMed ID: 19894105
[TBL] [Abstract][Full Text] [Related]
17. Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targeting.
Etrych T; Chytil P; Mrkvan T; Sírová M; Ríhová B; Ulbrich K
J Control Release; 2008 Dec; 132(3):184-92. PubMed ID: 18534705
[TBL] [Abstract][Full Text] [Related]
18. Star-shaped immunoglobulin-containing HPMA-based conjugates with doxorubicin for cancer therapy.
Etrych T; Mrkvan T; Ríhová B; Ulbrich K
J Control Release; 2007 Sep; 122(1):31-8. PubMed ID: 17631976
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
